Kidney Cancer Clinical Trial

Clinical Trial Finder Kidney Cancer Trials

An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma

See Locations Near You

Summary

The purpose of this study is to evaluate safety and efficacy of different administration regimens of nivolumab plus ipilimumab in subjects with renal cell carcinoma.

View Eligibility Criteria

Eligibility Criteria

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

Advanced Renal Cell Carcinoma
Must have full activity or, if limited, must be able to walk and carry out light activities such as light house work or office work
Must have at least 1 lesion with measurable disease

Exclusion Criteria:

Subjects with active central nervous system metastases
Subjects who received prior therapy with checkpoint inhibitor
Subjects with active, known or suspected autoimmune disease

Other protocol defined inclusion/exclusion criteria could apply

Study is for people with:

Kidney Cancer

Phase:

Phase 2

Estimated Enrollment:

104

Study ID:

NCT03029780

Recruitment Status:

Completed

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 10 Locations for this study

See Locations Near You

Cancer Specialists of North FL
Jacksonville Florida, 32256, United States
University Of Iowa Hospitals And Clinics
Iowa City Iowa, 52242, United States
Levine Cancer Institute
Charlotte North Carolina, 28204, United States
Local Institution
Pittsburgh Pennsylvania, 15212, United States
Local Institution
Waratah New South Wales, 2298, Australia
Local Institution
Westmead New South Wales, 2145, Australia
Local Institution
Herston Queensland, 4029, Australia
Local Institution
Elizabeth Vale South Australia, 5112, Australia
Local Institution
Malvern Victoria, 3144, Australia
Fundacion Arturo Lopez Perez
Santiago Metropolitana, 75009, Chile
Centro Internacional de Estudios Clinicos
Recoleta Santiago De Chile, , Chile
Load More

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Phase:

Phase 2

Estimated Enrollment:

104

Study ID:

NCT03029780

Recruitment Status:

Completed

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider